No Data
Zhengye Biotechnology | 6-K: Report of foreign private issuer (related to financial reporting)
Zhengye Biotechnology IPO of 1.5M Shrs Closes at $4 Each >ZYBT
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering
U.S. stock market update | Zhengye Bio (ZYBT.US) enters the U.S. stock market, opening up 22%.
On Tuesday, China's veterinary vaccine supplier Zhengye Biological (ZYBT.US) made its debut on the U.S. stock market, surging over 22% to $4.88 as of the time of writing.
Express News | Zhengye Biotechnology Shares Halted On Circuit Breaker To The Upside
Zhengye Biotechnology Reports Pricing Of Its IPO Of 1.50M Ordinary Shares At $4.00 Per Ordinary Share
No Data
